The team.
Caelium is led by a distinguished collective of founders and researchers with deep expertise in neuroscience, advanced brain imaging, and translational medicine. Our team brings decades of experience from world-class clinical environments, dedicated to converting complex scientific discoveries into effective real-world therapies.
This commitment to clinical excellence and research integrity ensures that every breakthrough at Caelium is grounded in rigorous science and driven by the goal of restoring cognitive resilience for patients everywhere.
Founders and leadership
Co-Founder & CEO
Donna J. Cross, PhD
Research Professor, University of Utah Department of Radiology and Imaging
Co-Founder & Director
Satoshi Minoshima, MD, PhD
Professor and Anne G. Osborn Endowed Chair, University of Utah Department of Radiology and Imaging
Chief Science Officer
Andrew Roberts, PhD
Associate Professor, University of Utah Department of Chemistry
Advisors
Clinical Trials Advisor
Elaine R. Peskind, MD
Research Professor, VA Puget Sound and University of Washington Department of Psychiatry and Behavioral Sciences
Advisor, Development
Claes Hornstrand, MBA
Affiliation to be supplied.
Clinical Advisor
Nicholas A. Frost, MD, PhD
Assistant Professor, University of Utah Department of Neurology
Regulatory Affairs Advisor
Carmen Betancourt Riche, MBA
More than 40 years in regulatory affairs with the FDA Centers for Drugs and Biologics
Commercialization Advisor
Annette Lavoie, PhD
Startup business advisor for university technology spinouts
Connected expertise
Built with research, development, and commercialization partners.
Working on something that belongs alongside ours?
We're open to research collaborations, licensing conversations, and questions about the science.
Get in touch